Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma

Fig. 2

Prognostic potential of SDC4 in PAAD patients by the “survival” package in R Software. A The expression of SDC4 in normal and tumor tissues using Wilcox test (P < 0.05); B The expression of SDC4 in different pancreatic cancer cells; C The expression of SDC4 in different TNM stages using Kruskal–Wallis tests; D The expression of SDC4 in different Grades; E and F Univariate and multivariate COX regression analyses of the factors affecting the prognosis and survival of PAAD; G Heat map of the main enrichment pathways of SDC4 from GSVA method; H The main enrichment pathways of SDC4 were analyzed by GSEA method

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us